Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 9
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

Industry News for MS (INforMS)
Wednesday, June 14, 2017
CMSC INforMS: Research Sheds Light on Who's Multiple Sclerosis Could Worsen »
A preliminary study by senior author Bianca Weinstock-Guttman, MD , has heightened researchers’ understanding about which...
Tuesday, June 13, 2017
CMSC INforMS: Sodium Intake And Its Association With Multiple Sclerosis Progression »
HealthDay News — There is no association between average 24-hour urine sodium levels and conversion from clinically isolat...
Saturday, June 10, 2017
CMSC INforMS: New Multiple Sclerosis drug, backed by 40 years of research, could halt disease »
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) is hold...
Thursday, June 8, 2017
CMSC INforMS: CMSC Revises Recommendations for Gadolinium Use in MRIs »
Editor’s note: Patient columnist Laura Kolaczkowski attended the 31st annual Consortium of Multiple Sclerosis Centers conf...
Thursday, June 8, 2017
CMSC INforMS: ‘MS from the Inside Out’ Uses Virtual Reality to Share What Life for Patients Is Like »
Virtual reality (VR) technology is most commonly associated with gaming and entertainment, but it’s expanding into a varie...
Friday, June 2, 2017   (0 Comments - view/add)
CMSC INforMS: #CMSC17 – Ocrevus, Progressive MS and Other Research Highlights »
The recent annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC) brought researchers and healthcare prof...
Friday, June 2, 2017
CMSC INforMS: Acne Therapy Reduces Rate of Multiple Sclerosis Progression, Canadian Study Reports »
A common acne medicine called minocycline can reduce the rate of multiple sclerosis progression in patients who are at e...
Wednesday, May 31, 2017
CMSC INforMS: #CMSC17 – Caregivers of MS Patients Say the Disease Exhausts Physically & Emotionally »
Most people who care for multiple sclerosis (MS) patients are happy to be caregivers, but they admit that their own emotio...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Ocrevus Lowers MS Relapse Rates Even Further in Extension Study »
Multiple sclerosis patients who benefited from Ocrevus ( ocrelizumab ) in two Phase 3 clinical trials continued to ben...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Physical Activity Halts Depression in Young MS Patients, Canadian Study Show »
Young multiple sclerosis (MS) patients who engage in physical activity can relieve symptoms of depression , concludes a C...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Celgene’s Investigational Therapy Ozanimod Safe, Effective in Treating RMS »
Long-term treatment for up to 12o weeks, with the investigational drug Ozanimod (RPC-1063), found to be effective and sa...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Rituxan-treated MS Patients 3x More Likely to Have Improved Brain Scans »
Multiple sclerosis patients who start Rituxan ( rituximab ) treatment are three times more likely to have unchanged or imp...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Cladribine Reduced Annual MS Relapse Rate by 55% to 57%, Trials Show »
Cladribine tablets reduced relapsing multiple sclerosis patients’ annual relapse rate by 55 to 57 percent, depending on t...
Tuesday, May 30, 2017
CMSC INforMS: #CMSC17 – Review Suggests Certain MS Patient Groups May Discontinue DMTs »
Older patients with secondary progressive multiple sclerosis ( SPMS ) as well as older relapsing patients whose MS has bee...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – Tysabri Improves Mental Outlook for Patients with Secondary Progressive MS »
Long-term therapy with Tysabri ( natalizumab ) significantly improved the mental state of people with secondary progress...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – Feeling of Social Stigma Makes Depression in MS More Likely, Study Reports »
People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression ,...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – MS Patients Should Contribute to Outcome Measure Development, Study Argues »
Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have d...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – MS Mobile Apps Link Clinicians and Patients, Improving Disease Management »
The use of multiple sclerosis (MS) mobile apps by patients and their clinicians encourages shared decision-making and help...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – Relapse After First Lemtrada Course No Indication of Poor Long-Term Outcome »
Multiple sclerosis (MS) patients who experienced a relapse between their first and second rounds of Lemtrada ( alemtuzum...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – Single Session of Ball-throwing Exercise Improves Balance Control in MS »
Patients with relapsing-remitting multiple sclerosis ( RRMS ) regain part of their balance control after a single training...
Friday, May 26, 2017
CMSC INforMS: #CMSC17 – Genentech Starts Site to Connect MS Patients and Caregivers with Resources »
Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can...
Saturday, May 20, 2017
CMSC INforMS: Multiple sclerosis study in cancer breakthrough »
A DRUG that helps the immune system destroy cancer has been developed by US scientists. It dramatically shrank deadly s...
Thursday, May 18, 2017
CMSC INforMS: CMSC 2017 - All About Teamwork in MS »
NEW ORLEANS — The Consortium of Multiple Sclerosis Centers (CMSC) annual meetings always aim to offer a multidisciplinary...
Friday, May 12, 2017
CMSC INforMS: Multiple sclerosis is more complex than once thought: Study »
Having a disabling disease can making living very difficult, especially when the source of the disability is not well unde...
Thursday, May 11, 2017
CMSC INforMS: Multiple Sclerosis Starts Five Years Before Onset of Disease, Study Suggests »
Symptoms of multiple sclerosis (MS) can appear 5 years before onset of the disease, according to a new study published in...
Wednesday, May 10, 2017
CMSC INforMS: The Hidden Costs of Multiple Sclerosis »
MS is sneaky. It is expert at evading detection and diagnosis, and often brings a host of invisible symptoms that may come...
Monday, May 8, 2017
CMSC INforMS: What Triggers Multiple Sclerosis? Scientists May Have Identified the Culprit »
Scientists have identified a cellular mechanism that may be responsible for the development of multiple sclerosis (MS), an...
Friday, May 5, 2017
CMSC INforMS: Vitamin D Deficiency Affects Cognition in Multiple Sclerosis »
Results of a study published in a recent issue of Scientific Reports 1 showed significant improvements in cognitive perfo...
Tuesday, May 2, 2017
CMSC INforMS: Nose2Brain – project to improve Multiple Sclerosis therapy »
Medically active substances are usually distributed via the blood – either directly or indirectly. In many diseases, howev...
Monday, May 1, 2017
CMSC INforMS: #CMSC2017 – Experts to Focus on MS Patient Care at CMSC Annual Meeting in New Orleans »
The 31st Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) will take place May 24-27 at the Ernest N...
Thursday, April 27, 2017
CMSC INforMS: New Survey Finds MS Patients Struggle with Misdiagnosis and Invisible Symptoms »
PHILADELPHIA, PA --(Marketwired - April 27, 2017) - MS in America 2017 , a national survey of more than 5,300 individuals...
Wednesday, April 26, 2017
CMSC INforMS: Why the Future of Science Is Crucial to the MS Community »
Everything around us, and within us, begins with science. Science is important to the future of humanity’s well-being....
Tuesday, April 25, 2017
CMSC INforMS: Health Reform: How is Pharma Affected? »
Reforming the health care industry is an increasingly complex challenge due to multiple layers of legislation already in p...
Tuesday, April 25, 2017
CMSC INforMS: Is 'No Evidence of Disease Activity' a Misnomer in MS? »
BOSTON -- Multiple sclerosis patients who are not having relapses, not becoming more disabled according to a standard meas...
Tuesday, April 25, 2017
CMSC INforMS: How Biotech is Mastering Multiple Sclerosis: A Review »
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis. R...

Displaying page 1 of 9
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

3 University Plaza Drive, Suite 116
Hackensack, NJ 07601
Tel: 201-487-1050 | Fax: 862-772-7275
Privacy Policy | Disclaimer